Log In
Print this Print this

Anthrax vaccine (Nfu-PA-D4-RNP)

  Manage Alerts
Collapse Summary General Information
Company Molecular Targeting Technologies Inc.
DescriptionRecombinant rabies virus nucleoprotein in combination with anthrax protective antigen
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAnthrax
Indication DetailsPrevent anthrax
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today